Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study

Introduction: Chronic, broad-spectrum immunosuppressive therapy (IST) can be associated with side effects in many people with generalized myasthenia gravis (gMG), and treatment guidelines recommend that the IST dose be tapered once patients achieve a stable treatment response. We therefore examined...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Richard J. Nowak, Srikanth Muppidi, Said R. Beydoun, Fanny L. O'Brien, Marcus Yountz, James F. Howard
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2020-11-01
Reeks:	Frontiers in Neurology
Onderwerpen:	eculizumab myasthenia gravis immunosuppressive therapy refractory acetylcholine receptor
Online toegang:	https://www.frontiersin.org/articles/10.3389/fneur.2020.556104/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!